hsa-miR-93-5p

ncRNA information

ncRNA name

hsa-miR-93-5p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

Smad7

Cancer information

Cancer name

Prolactinoma

Cancer site

Pituitary Gland

Treatment information

Treatment type

Chemotherapy

Drug

Bromocriptine

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-93-5p could enhance the drug resistance of prolactinoma cells by regulation of TGF-Ī²1/Smad3-dependent fibrosis.

Tissue resource

prolactinoma samples

Experiment

Western blot,Luciferase reporter assay


Institute

the First Affiliated Hospital, Sun-Yet Sen University

Country

China

Continent

Asia